Exploration on the Value of MRD Based on ctDNA Detection in Predicting Recurrence of Resected Non-small Cell Lung Cancer
NCT05965024
·
clinicaltrials.gov ↗
RECRUITING
Status
377
Enrollment
OTHER
Sponsor class
Conditions
Non-small Cell Lung Cancer
Sponsor
Shanghai Pulmonary Hospital, Shanghai, China